Latest Headlines

PR Newswire

U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease

PR Newswire

Black Dragon Capital℠ Founder and CEO Louis Hernandez, Jr. To Join Two Panels at the New America Alliance International Symposium in Puerto Rico

PR Newswire

Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market